TickerFactsScreenerDevelopers

Anika Therapeutics, Inc. (ANIK) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: $5.59M2010: $7.54M2011: $13.97M2012: $19.72M2013: $32.61M2014: $61.45M2015: $48.13M2016: $50.61M2017: $45.73M2018: $21.75M2019: $34.25M2020: -$28.32M2021: $2.62M2022: $3.67M2023: $844.0K2024: -$5.10M2025: -$11.05M-$11.05M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$11.05M-116.6%
2024-$5.10M-704.4%
2023$844.0K-77.0%
2022$3.67M+40.3%
2021$2.62M+109.2%
2020-$28.32M-182.7%
2019$34.25M+57.5%
2018$21.75M-52.4%
2017$45.73M-9.6%
2016$50.61M+5.1%
2015$48.13M-21.7%
2014$61.45M+88.4%
2013$32.61M+65.4%
2012$19.72M+41.2%
2011$13.97M+85.3%
2010$7.54M+34.9%
2009$5.59M—